comparemela.com

Steve Ruchefsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Regel Therapeutics Awarded $1 Million from HS Chau Women in Enterprising Science Program at the Innovative Genomics Institute to Continue Developing Its Gene Modulation Technology

/PRNewswire/ Regel Therapeutics, a next generation gene therapy company utilizing proprietary technology to modulate gene expression, today announced that.

United statesUnited kingdomSolina chau hoi shuenEmmanuelle charpentierJennifer doudnaSteve ruchefskyNavneet matharuInnovative genomics instituteWomen in enterprising science programChau foundationChief scientific officerEnterprising science programHorizons venturesRegel therapeutics inc

Regel Therapeutics details its proprietary T3 platform and development pipeline on its newly launched website, expands its Board of Directors and announces its Scientific Advisory Board

/PRNewswire/ Regel Therapeutics, a next generation gene therapy company utilizing proprietary technology to develop clinical products modulating gene.

United statesUnited kingdomSan franciscoWendy chungOrrin devinskySteve ruchefskyAndrew schiermeierNadav ahituvKevin benderGord fishellUniversity of californiaBroad instituteDepartment of neurologyHarvard medical schoolEpilepsy centerTherapeutic technology

vimarsana © 2020. All Rights Reserved.